Trial Profile
Irritable Bowel Syndrome Evaluation and Treatment in Primary Care
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 21 Jul 2012
Price :
$35
*
At a glance
- Drugs Bifidobacterium infantis (Primary) ; Nitazoxanide (Primary) ; Pancrelipase (Primary)
- Indications Irritable bowel syndrome
- Focus Therapeutic Use
- 21 Jul 2012 New trial record